Physician profile
Benny Screws
NPI 1811489123
$1,734.61
in general payments reported to CMS, 2019-2025
13 companies · $862 in 2025
The $862 reported for 2025 was more than what 75% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $211 · 2020: $115 · 2021: $225 · 2022: $323 · 2025: $862.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $862.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $861.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $679.58 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $528.54 | 2019-2025 | Airsupra |
| Alexion Pharmaceuticals, INC. | $111.68 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $77.63 | 2019-2022 | |
| Penumbra, INC. | $70.85 | 2025 | Indigo System |
| Novartis Pharmaceuticals Corporation | $58.68 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $46.29 | 2019-2022 | |
| Pfizer INC. | $38.01 | 2019-2020 | |
| Melinta Therapeutics, LLC | $31.60 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $26.68 | 2019 | |
| Aroa Biosurgery Incorporated | $26.67 | 2022 | |
| Gilead Sciences, INC. | $23.25 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $15.15 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benny Screws listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.